CervoMed Inc. Deferred Tax Assets, Tax Deferred Expense, Compensation and Benefits
CervoMed Inc. (CRVO) had Deferred Tax Assets, Tax Deferred Expense, Compensation and Benefits of $1.56 million as of 2013-12-31, per its 10-K/A filed 2014-04-23.
Discontinued › Notes › Income Taxes › Components of Deferred Tax Assets and Liabilities › Deferred Tax Assets, Net of Valuation Allowance › Deferred Tax Assets, Gross › Deferred Tax Assets, Tax Deferred Expense › Deferred Tax Assets, Tax Deferred Expense, Compensation and Benefits
us-gaap:DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefits · last filed 2014-04-23
- 2013-12-31: Deferred Tax Assets, Tax Deferred Expense, Compensation and Benefits $1.56M.
- 2012-12-31: Deferred Tax Assets, Tax Deferred Expense, Compensation and Benefits $883.79K.
| Period end | Deferred Tax Assets, Tax Deferred Expense, Compensation and Benefits |
|---|---|
| 2013-12-31 | $1.56M 10-K/A · filed 2014-04-23 |
| 2012-12-31 | $883.79K 10-K/A · filed 2014-04-23 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Celularity Inc (CELU) | United States | $0.038B | -0.34 |
| Edesa Biotech, Inc. (EDSA) | Canada | $0.039B | |
| Actinium Pharmaceuticals, Inc. (ATNM) | United States | $0.038B | 2.73 |
| FILANA THERAPEUTICS, INC. (FLNA) | United States | $0.038B | -1.05 |
| PMGC Holdings Inc. (ELAB) | United States | $0.037B | |
| Karyopharm Therapeutics Inc. (KPTI) | United States | $0.039B | -0.98 |
| BriaCell Therapeutics Corp. (BCTX) | $0.037B | ||
| Seres Therapeutics, Inc. (MCRB) | United States | $0.036B | -3.45 |
| Incannex Healthcare Inc. (IXHL) | $0.040B | -22.32 | |
| MIRA PHARMACEUTICALS, INC. (MIRA) | United States | $0.036B | -4.30 |